Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8040)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 28, 2014 (publication date) through Jul 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim HY, Kim W. Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013. World J Gastroenterol 2014; 20(40): 14581-14588 [PMID: 25356022 DOI: 10.3748/wjg.v20.i40.14581] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14581.htm |
| Number | Citing Articles |
| 1 |
Xiaoguang Wang, Xiaodan Yang, Fei Chen, Shaohan Wu, Zhengwei Song, Jianguo Fei, Giovanni Marasco. Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8864655
|
| 2 |
Mauro Viganò, Giuseppe Serra, Giovanni Casella, Glenda Grossi, Pietro Lampertico. Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders. Expert Opinion on Biological Therapy 2016; 16(7): 917 doi: 10.1080/14712598.2016.1177017
|
| 3 |
Fernando Bessone, Melisa Dirchwolf. Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations. World Journal of Hepatology 2016; 8(8): 385-394 doi: 10.4254/wjh.v8.i8.385
|
| 4 |
João Marcello de Araujo-Neto, Gabriela Sousa Guimarães, Flavia Ferreira Fernandes, Marcelo A. Soares. Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies. Viruses 2022; 14(8): 1780 doi: 10.3390/v14081780
|
| 5 |
Yutaka Tsukune, Makoto Sasaki, Norio Komatsu. Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma. Cancers 2019; 11(11): 1819 doi: 10.3390/cancers11111819
|
| 6 |
Cindy Cheng, Jocelyn R. Hauser, Caitlin Otto, Yi-Wei Tang. Architect i2000 SR has improved turnaround time for infectious disease serology testing over Vitros ECiQ. Diagnostic Microbiology and Infectious Disease 2020; 97(3): 115049 doi: 10.1016/j.diagmicrobio.2020.115049
|
| 7 |
R. Ozaras, G. Corti, S. Ruta, K. Lacombe, M.U. Mondelli, W.L. Irwing, M. Puoti, A. Khalighi, M.L. Santos, A. Harxhi, I. Lazarevic, V. Soriano, J. Gervain, H. Leblebicioglu, D. Salmon, J.E. Arends. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe. Clinical Microbiology and Infection 2015; 21(11): 1027 doi: 10.1016/j.cmi.2015.07.002
|
| 8 |
Ji Yun Lee, Sung Hee Lim, Min‐Young Lee, Haesu Kim, Dong Hyun Sinn, Geum‐Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Chul Won Jung, Jun Ho Jang, Won Seog Kim, Seok Jin Kim, Kihyun Kim. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver International 2015; 35(11): 2363 doi: 10.1111/liv.12838
|
| 9 |
Xing Cao, Yafei Wang, Panyun Li, Wei Huang, Xiaojuan Lu, Hongda Lu. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.685706
|
| 10 |
Michael Hallek, Bruce D. Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillermo Dighiero, Hartmut Döhner, Peter Hillmen, Michael Keating, Emili Montserrat, Nicholas Chiorazzi, Stephan Stilgenbauer, Kanti R. Rai, John C. Byrd, Barbara Eichhorst, Susan O’Brien, Tadeusz Robak, John F. Seymour, Thomas J. Kipps. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 2018; 131(25): 2745 doi: 10.1182/blood-2017-09-806398
|
| 11 |
Tomasz I. Michalak. Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00853
|
| 12 |
Alessandro Loglio, Mauro Viganò, Glenda Grossi, Sara Labanca, Maria Goldaniga, Alessandra Pompa, Lucia Farina, Mariagrazia Rumi, Paolo Corradini, Floriana Facchetti, Giovanna Lunghi, Luca Baldini, Pietro Lampertico. Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Digestive and Liver Disease 2019; 51(3): 419 doi: 10.1016/j.dld.2018.08.024
|
| 13 |
Ji Won Han, Hyun Yang, Hae Lim Lee, Si Hyun Bae, Jong Young Choi, Jong‐Wook Lee, Hee Je Kim, Seok Lee, Seok Goo Cho, Chang Ki Min, Dong Wook Kim, Seung Kew Yoon. Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies. Hepatology Research 2016; 46(7): 657 doi: 10.1111/hepr.12603
|
| 14 |
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nagral, Amarender S. Puri, Padaki N. Rao, Neeraj Saraf, Vivek A. Saraswat, Sanjeev Sehgal, Praveen Sharma, Koticherry T. Shenoy, Manav Wadhawan. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids. Journal of Clinical and Experimental Hepatology 2018; 8(4): 403 doi: 10.1016/j.jceh.2018.06.010
|
| 15 |
Li‐Ping Shui, Yan Zhu, Xiao‐Qin Duan, Yu‐Ting Chen, Li Yang, Xiao‐Qiong Tang, Hong‐Bin Zhang, Qing Xiao, Li Wang, Lin Liu, Xiao‐Hua Luo. HBsAg (−)/HBsAb (−)/HBeAg (−)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B‐cell lymphoma receiving rituximab based immunochemotherapy. Journal of Medical Virology 2023; 95(2) doi: 10.1002/jmv.28549
|
| 16 |
Lu Han, Jian Zhou, Keshu Zhou, Xinghu Zhu, Lingdi Zhao, Baijun Fang, Qingsong Yin, Xudong Wei, Hu Zhou, Linlin Li, Bengling Xu, Jishuai Zhang, Yongping Song, Quanli Gao. Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus. Journal for ImmunoTherapy of Cancer 2020; 8(2): e000927 doi: 10.1136/jitc-2020-000927
|
| 17 |
Philippe Colson, Patrick Borentain, Diane Coso, Anne Motte, Therese Aurran-Schleinitz, Aude Charbonnier, Anne Marie Stoppa, Christian Chabannon, Mélanie Serrero, Julie Bertrand, Fabrice Barlesi, Jacques Serratrice, Isabelle Portal, Daniele Botta-Fridlund, Catherine Tamalet, René Gerolami. Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase. Virology 2015; 484: 354 doi: 10.1016/j.virol.2015.06.017
|
| 18 |
Lidan Hou, Jie Zhao, Shaobing Gao, Tong Ji, Tianyu Song, Yining Li, Jingjie Wang, Chenlu Geng, Min Long, Jiang Chen, Hui Lin, Xiujun Cai, Yong Cang. Restriction of hepatitis B virus replication by c-Abl–induced proteasomal degradation of the viral polymerase. Science Advances 2019; 5(2) doi: 10.1126/sciadv.aau7130
|
| 19 |
Valentina Varisco, Mauro Viganò, Alberto Batticciotto, Pietro Lampertico, Antonio Marchesoni, Patrizia Gibertini, Raffaele Pellerito, Guido Rovera, Roberto Caporali, Monica Todoerti, Michele Covelli, Antonella Notarnicola, Fabiola Atzeni, Piercarlo Sarzi-Puttini. Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study. The Journal of Rheumatology 2016; 43(5): 869 doi: 10.3899/jrheum.151105
|
| 20 |
Yangyu Zhang, Linlin Qu, Yuchen Pan, Yanhua Wu, Jing Jiang, Julie Zhu. Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort. PLOS ONE 2023; 18(12): e0286441 doi: 10.1371/journal.pone.0286441
|
| 21 |
Yutaka Tsutsumi, Yoshiya Yamamoto, Shinichi Ito, Hiroyuki Ohigashi, Souichi Shiratori, Hirohito Naruse, Takanori Teshima. Hepatitis B virus reactivation with a rituximab-containing regimen. World Journal of Hepatology 2015; 7(21): 2344-2351 doi: 10.4254/wjh.v7.i21.2344
|
| 22 |
Kishor Pant, Amit K. Mishra, Saman Man Pradhan, Baibaswata Nayak, Prasenjit Das, Dr Shalimar, Anoop Saraya, Senthil K. Venugopal. Butyrate inhibits HBV replication and HBV‐induced hepatoma cell proliferation via modulating SIRT‐1/Ac‐p53 regulatory axis. Molecular Carcinogenesis 2019; 58(4): 524 doi: 10.1002/mc.22946
|
| 23 |
Taku Mizutani, Shunichi Matsuoka, Daiichirou Kikuta, Jou Hayama, Shintaro Nagai, Naoki Matsumoto, Hitomi Nakamura, Kazushige Nirei, Tatsuo Kanda, Mitsuhiko Moriyama, Katsuhiro Miura, Masami Takei, Masahiko Sugitani. Successful Management of a Patient with Multiple Nucleos(t)ide Analogue-Resistant Hepatitis B Virus and Diffuse Large B Cell Lymphoma Using Tenofovir Disoproxil Fumarate: A Case Report. Journal of Nihon University Medical Association 2019; 78(5): 295 doi: 10.4264/numa.78.5_295
|
| 24 |
Shigeru Kusumoto, Luca Arcaini, Xiaonan Hong, Jie Jin, Won Seog Kim, Yok Lam Kwong, Marion G. Peters, Yasuhito Tanaka, Andrew D. Zelenetz, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. Blood 2019; 133(2): 137 doi: 10.1182/blood-2018-04-848044
|
| 25 |
Resat Ozaras, Hawa’a Khodor, Nergul Yetim, Umut Kaan Unal, Yunus Emre Demirhan, Goknil Gultekin, Burak Isal. Monotherapy for hepatitis B infection: a review of treatment options. Expert Review of Anti-infective Therapy 2015; 13(12): 1457 doi: 10.1586/14787210.2015.1093934
|
| 26 |
Abdullah S. Shaikh, Susan C. Abraham, Lan S. Wang, Harrys A. Torres, Hao Chi Zhang. Viral Hepatitis B Reactivation With Delayed Cholestatic Effect Secondary to Acalabrutinib. ACG Case Reports Journal 2024; 11(6): e01387 doi: 10.14309/crj.0000000000001387
|
| 27 |
Satoshi Hibi, Kenji Ina, Shu Yuasa, Nobuto Ito, Yuko Shirokawa, Kengo Nanya, Yuko Kato, Takashi Yoshida, Satoshi Kayukawa. Management of Hepatitis B Virus Reactivation after the Completion of Cancer Chemotherapy using a Plan-do-Check-Act Cycle. Journal of Cancer Research Updates 2022; 11: 78 doi: 10.30683/1929-2279.2022.11.11
|